Lucid Diagnostics Inc. LUCD
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-10-14
Chart by TradingView
3/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $4.7M | $4.3M | $2.4M | $377,000 | $500,000 |
| Gross profit | — | — | — | $377,000 | $500,000 |
| Operating income | -$49.6M | -$46.1M | -$48.5M | -$56.3M | -$27.4M |
| Net income | -$58.0M | -$45.5M | -$52.7M | -$56.2M | -$28.1M |
| Operating cash flow | -$46.5M | -$44.1M | -$32.8M | -$29.7M | -$17.7M |
| Free cash flow | -$46.7M | -$44.4M | — | -$32.9M | -$18.5M |
| Total assets | $40.4M | $30.7M | $27.3M | $32.5M | $59.0M |
| Total liabilities | $29.5M | $25.3M | $29.6M | $9.5M | $4.3M |
| Shareholders' equity | $10.9M | $5.4M | -$2.3M | $23.0M | $54.7M |
| Ratios | |||||
| Gross margin | — | — | — | 100.0% | 100.0% |
| Operating margin | -1054.8% | -1059.6% | -1996.8% | -14920.7% | -5483.8% |
| Net margin | -1232.7% | -1047.6% | -2169.1% | -14899.5% | -5615.6% |
| FCF margin | -992.0% | -1022.5% | — | -8722.8% | -3706.0% |
| Return on assets | -143.4% | -148.2% | -193.1% | -172.8% | -47.6% |
| Return on equity | -530.4% | -844.5% | 2278.9% | -243.7% | -51.3% |
| Current ratio | 1.31 | 1.07 | 0.75 | 2.89 | 13.45 |
| Revenue growth | 8.3% | 79.0% | 544.0% | -24.6% | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 499,661 | $574,610 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001799011 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.